Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026)

Avantor (AVTR) recorded quarterly Liabilities and Shareholders Equity of $11.7 billion in Q1 2026, down 1.12% quarter-over-quarter from $11.8 billion in Q4 2025, and down 5.38% on a YoY basis from $12.3 billion in Q1 2025.

Avantor (AVTR) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

Avantor's Liabilities and Shareholders Equity history runs 9 years deep, the most recent figure standing at $11.7 billion for Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 5.38% year-over-year to $11.7 billion; the TTM figure through Mar 2026 stood at $47.9 billion (down 4.13% YoY), while the FY2025 annual figure was $11.8 billion, down 2.64% from the prior year.
  • Liabilities and Shareholders Equity was $11.7 billion for Q1 2026 at Avantor, down from $11.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $13.8 billion in Q1 2022 to a low of $5.3 billion in Q4 2022.
  • Historically, Liabilities and Shareholders Equity has averaged $11.9 billion across 5 years, with a median of $12.8 billion in 2024.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity jumped 103.38% in 2024, then dropped 9.07% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $5.3 billion in 2022, then climbed by 13.4% to $6.0 billion in 2023, then surged by 103.38% to $12.1 billion in 2024, then slipped by 2.64% to $11.8 billion in 2025, then retreated by 1.12% to $11.7 billion in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $11.7 billion (Q1 2026), $11.8 billion (Q4 2025), and $11.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Intuitive Surgical 151.46 Bn 147.07 Bn 1.83 Bn 20.11 Bn
2 Becton Dickinson 43.06 Bn 42.04 Bn 2.15 Bn 50.83 Bn
3 Medline 29.49 Bn 35.33 Bn 1.84 Bn 39.01 Bn
4 Resmed 28.58 Bn 26.92 Bn 890.98 Mn 8.78 Bn
5 West Pharmaceutical Services 24.11 Bn 23.59 Bn 296.40 Mn 4.11 Bn
6 Solventum 14.37 Bn 14.37 Bn 1.10 Bn 14.10 Bn
7 Cooper Companies 13.38 Bn 13.25 Bn 735.40 Mn 12.48 Bn
8 Align Technology 12.72 Bn 11.66 Bn 736.59 Mn 6.31 Bn
9 Baxter International 10.32 Bn 8.27 Bn 891.00 Mn 19.85 Bn
10 Avantor 6.71 Bn 6.43 Bn 500.70 Mn 11.66 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.66 Bn
Dec 31, 2025 11.79 Bn
Sep 30, 2025 11.68 Bn
Jun 30, 2025 12.78 Bn
Mar 31, 2025 12.33 Bn
Dec 31, 2024 12.11 Bn
Sep 30, 2024 12.84 Bn
Jun 30, 2024 12.69 Bn
Mar 31, 2024 12.76 Bn
Dec 31, 2023 5.96 Bn
Sep 30, 2023 12.80 Bn
Jun 30, 2023 13.06 Bn
Mar 31, 2023 13.40 Bn
Dec 31, 2022 5.25 Bn
Sep 30, 2022 13.11 Bn
Jun 30, 2022 13.43 Bn
Mar 31, 2022 13.84 Bn
Dec 31, 2021 4.86 Bn
Sep 30, 2021 12.20 Bn
Jun 30, 2021 11.25 Bn